Wells Fargo’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1
Closed -$33 7956
2022
Q1
$0 Buy
+1
New +$33 ﹤0.01% 8278
2021
Q2
Sell
-1
Closed -$33 7772
2021
Q1
$0 Buy
+1
New +$33 ﹤0.01% 7665
2020
Q4
Sell
-1
Closed -$31 7302
2020
Q3
$0 Buy
+1
New +$30 ﹤0.01% 7191
2020
Q2
Sell
-1
Closed -$29 7080
2020
Q1
$0 Hold
1
﹤0.01% 7082
2019
Q4
$0 Hold
1
﹤0.01% 6890
2019
Q3
$0 Hold
1
﹤0.01% 6868
2019
Q2
$0 Buy
+1
New +$25 ﹤0.01% 6733

Other funds holding IEIH

Wells Fargo's IEIH Position: Q2 2022 in Review

Wells Fargo sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q2 2022, closing a stake of 1 share — an estimated $33 sold.

Wells Fargo first reported a position in IEIH in Q2 2019 and held it in 7 quarters. The position peaked at $0 in Q1 2022. 18 funds tracked by Wall St. Rank hold IEIH as of Q2 2022.

  • Wells Fargo reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q2 2022 after selling out during the quarter.
  • Wells Fargo sold 1 iShares Evolved U.S. Innovative Healthcare ETF share in Q2 2022, an estimated $33.
  • Wells Fargo first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q2 2019 and held it in 7 quarters.
  • Wells Fargo's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $0 in Q1 2022.
  • 18 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q2 2022.

Based on Wells Fargo's 13F filing for Q2 2022, filed 12 Aug 2022.